Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial
Authors:
- Takuji OkusakaTakuji Okusaka
- Hiroshi KasugaiHKHiroshi Kasugai
- Yasukazu ShioyamaYSYasukazu Shioyama
- Katsuaki TanakaKTKatsuaki Tanaka
- Masatoshi KudoMasatoshi Kudo
- Hiromitsu SaishoHSHiromitsu Saisho
- Yukio OsakiYOYukio Osaki
- Michio SataMSMichio Sata
- Shigetoshi FujiyamaSFShigetoshi Fujiyama
- Takashi KumadaTKTakashi Kumada
- Keiko SatoKSKeiko Sato
- Seiichiro YamamotoSYSeiichiro Yamamoto
- 1 December 2009
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 51 (6) , 1030-1036
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour, and Welfare of Japan (11-15)
This publication has 18 references indexed in Scilit:
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trialJournal of Hepatology, 1998
- Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institutionHepatology, 1998
- A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 1995
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaJournal of Hepatology, 1990
- Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary reportEuropean Journal of Cancer and Clinical Oncology, 1983
- A LIPOPHILIC DERIVATIVE OF NEOCARZINOSTATIN A Polymer Conjugation of an Antitumor Protein Antibiotic*International Journal of Peptide and Protein Research, 1979